{"ticker": {"uuid": "cc0b13dd-0d97-40b5-8d9c-692f14af49a3", "symbol": "QGEN", "name": "Qiagen NV", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "Qiagen highlights testing tools amid U.S. cyclosporiasis outbreak By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQeDkyQ25HTk1sVzg2c2RJSExjMzlJTm9IeXEwN2tZNjFJV2NiWlFva1FFb3dvTmZqc1ZiMFNhSl9VQ1IzY1ZIVkhiMnlpeUJmODl2c3dFNFlxR3F3N0pHNmx3Z3JwM0NadkwyMlJNaVJXVWNvRm5vQ2RyNnZsMmJmZEZCNk1aZ1ZNTEJmUGlvdEJwOW5PRTEtWTVDN1loXy1PTGhuUUk1Tng5ZFV5SVIxNC1CMGVWS05ya0w0S3lITGNVZDBSaElXdHd5aXlLdXAweFE?oc=5", "source_name": "Investing.com India", "published_at": "2026-07-15T23:19:25+00:00", "published_display": "15 Jul 2026 23:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QIAGEN Highlights Molecular Testing Solutions Supporting Response to Growing U.S. Cyclospora Outbreak", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/qiagen-highlights-molecular-testing-solutions-200500903.html", "source_name": "Business Wire", "published_at": "2026-07-15T20:05:00+00:00", "published_display": "15 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Over 1,600 U.S. Cyclospora Cases; QIAGEN Test Takes an Hour", "summary": "QIAGEN (QGEN) has highlighted its molecular testing solutions for the growing number of cyclosporiasis cases in the U.S., with over 1,600 confirmed infections since May 2026. The company's FDA-cleared QIAstat-Dx Gastrointestinal Panel 2 can detect Cyclospora in about an hour as p", "url": "https://www.stocktitan.net/news/QGEN/qiagen-highlights-molecular-testing-solutions-supporting-response-to-bx81opg7eixm.html", "source_name": "Stock Titan", "published_at": "2026-07-15T19:41:58", "published_display": "15 Jul 2026 19:41", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QIAGEN sets August 6 webcast for second-quarter results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOOHlYeUhfLVozM05NLTZGU00yZWdJM0NfQ0xwQ1E0Q1djcGN2enM2M2VqRDVxbmtILWV6NkNIeDRPRGZlTVJLVERPZ24zLXdwVXBrTmhLaGpYLXRMUVAxYmRHZjJlVGtlTGF0R2pvZWVtdzZaMU1uNnNZSEZhVF9PWmFkUGlEb1pSVnZhNW12Y2xNRWIwbng1b0wyXzFRUHEtdl9tT0xvbFI?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T12:50:50+00:00", "published_display": "15 Jul 2026 12:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Berenberg Downgrades Qiagen Rating, Price Target Amid Rising Competition, Growth Concerns", "summary": "Berenberg has downgraded Qiagen's rating and reduced its price target, citing increasing competition and decelerating growth potential. This adjustment comes as the analytical instruments and consumables market faces new challenges. Investors will be watching how Qiagen responds ", "url": "https://www.moomoo.com/news/post/73001950/berenberg-downgrades-qiagen-rating-price-target-amid-rising-competition-growth", "source_name": "Moomoo", "published_at": "2026-07-15T13:41:58", "published_display": "15 Jul 2026 13:41", "sentiment": "negative", "sentiment_pct": 28, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QIAGEN N.V. to Release Results for Q2 2026 and Hold Webcast", "summary": "QIAGEN N.V. announced its plans to release second-quarter 2026 financial results on Wednesday, August 5, 2026, followed by a conference call on Thursday, August 6, 2026. Interested parties can access the call via callback connection, dial-in numbers, or a live audio webcast, and ", "url": "https://www.businesswire.com/news/home/20260715523254/en/QIAGEN-N.V.-to-Release-Results-for-Q2-2026-and-Hold-Webcast", "source_name": "Business Wire", "published_at": "2026-07-15T12:41:58", "published_display": "15 Jul 2026 12:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QIAGEN Expands QIAstat-Dx Bloodstream Infection Testing Menu in Europe", "summary": "QIAGEN has launched the CE-IVDR-certified QIAstat-Dx BCID GN Plus AMR Panel in Europe, significantly expanding its bloodstream infection testing capabilities. This new panel, alongside an existing one, can detect 33 pathogen targets and 28 antimicrobial resistance markers from po", "url": "https://www.biospace.com/press-releases/qiagen-expands-qiastat-dx-bloodstream-infection-testing-menu-in-europe", "source_name": "BioSpace", "published_at": "2026-07-15T05:41:36", "published_display": "15 Jul 2026 05:41", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Qiagen N.V. \u2013 NYSE:QGEN", "summary": "This article focuses on the enterprise value to revenue forward metric for Qiagen N.V. (NYSE: QGEN). It appears to be a financial data point presented on TradingView's platform, indicating a specific period and value for this financial ratio. The content itself seems to be a data", "url": "https://www.tradingview.com/symbols/NYSE-QGEN/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-15T00:41:36", "published_display": "15 Jul 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen Launches QIAstat-Dx Bloodstream Infection Testing in Europe", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/qiagen-launches-qiastat-dx-bloodstream-213136270.html", "source_name": "MT Newswires", "published_at": "2026-07-14T21:31:36+00:00", "published_display": "14 Jul 2026 21:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen launches bloodstream infection test panel in Europe By Investing.com", "summary": "QIAGEN N.V. (NYSE:QGEN) has launched its CE-IVDR-certified QIAstat-Dx BCID GN Plus AMR Panel in Europe for bloodstream infection testing, capable of detecting gram-negative bacterial pathogens and antimicrobial resistance markers. This new panel complements an existing one, colle", "url": "https://za.investing.com/news/stock-market-news/qiagen-launches-bloodstream-infection-test-panel-in-europe-93CH-4368823", "source_name": "Investing.com South Africa", "published_at": "2026-07-14T21:41:36", "published_display": "14 Jul 2026 21:41", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New QIAGEN test detects bloodstream pathogens and resistance in about an hour", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOMDZxdk9BMlR6VW1pUXVWSUhtY0dydnpKd295aVdQTXFFOWxJU0ZfNGY1X0JyRU9jUlhTV0hzb1ZDQlJCX2VGazUybHluYzdKNERzSGtPdzF3UVlVMEg2QjhzNVV1azBuOGMzTEVuQXlsNDdVbUVEYVFVckFTZDRUTWpWTkRtZGVsSTZVa2lVajJmalJiTGZvOTJXcnpxdkg1NnFMTEVORnRTbTdEeVdtOTZqYndlaDVybGV3?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T20:07:14+00:00", "published_display": "14 Jul 2026 20:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Berenberg Downgrades QIAGEN to Hold From Buy, Cuts Price Target to $45.50 From $59", "summary": "Berenberg has downgraded QIAGEN (QGEN) stock from Buy to Hold and significantly cut its price target from $59 to $45.50. This change in rating and price target suggests a more cautious outlook from the investment bank regarding QIAGEN's future performance.", "url": "https://www.moomoo.com/news/post/72927908/berenberg-downgrades-qiagen-to-hold-from-buy-cuts-price-target?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-14T11:41:36", "published_display": "14 Jul 2026 11:41", "sentiment": "negative", "sentiment_pct": 28, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock holds steady as diagnostics demand shapes long term outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQelQ5VFNlelhIMTJsZk10QUwxRE5sNFBOdEVJVVdSdHVFaS03NjJTXzE1NUZxNUJVUDB1a1k2VFlpM3IzYjFxX3dkVFg5UkxfRGt1Nl8takZ6Y0NSLWFHRzlIeFFwVnhHYlktNUIzN3JGZlZ6OUxwQlo3T1ZGUVJ4T2tXMnlzUlA1UVpoMFFpVlhxTlZhUTRUVWI2WjZRZHFIRHp4R0MyZE53SWI1Tk9KRmg0T3c2QkhnWEw3dDFXZXFCNTVpdDJJWVBHQQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-14T09:00:58+00:00", "published_display": "14 Jul 2026 09:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Berenberg cuts Qiagen stock rating on competitive pressures", "summary": "Berenberg has downgraded Qiagen NV to Hold from Buy and reduced its price target due to competitive pressures on its QuantiFERON franchise and weakening expectations for U.S. life sciences research spending. Despite a new buyback program and the stock appearing slightly undervalu", "url": "https://www.investing.com/news/analyst-ratings/berenberg-cuts-qiagen-stock-rating-on-competitive-pressures-93CH-4789883", "source_name": "Investing.com", "published_at": "2026-07-14T08:52:38", "published_display": "14 Jul 2026 08:52", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Berenberg downgrades Qiagen stock rating on competitive concerns", "summary": "Berenberg downgraded Qiagen NV's stock rating from Buy to Hold and lowered its price target due to concerns about the deterioration of its outlook in the first half of 2026 and increasing competitive pressure for its QuantiFERON franchise. The firm cited lower immigration demand ", "url": "https://www.investing.com/news/analyst-ratings/berenberg-downgrades-qiagen-stock-rating-on-competitive-concerns-93CH-4789902", "source_name": "Investing.com", "published_at": "2026-07-14T08:52:38", "published_display": "14 Jul 2026 08:52", "sentiment": "negative", "sentiment_pct": 32, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QIAGEN NV : Reduced to Neutral by Berenberg", "summary": "Berenberg has downgraded its recommendation for QIAGEN NV to Neutral, lowering the target price from EUR 50 to EUR 40. This revision comes amidst recent news regarding potential takeover interest in Qiagen from private equity firms like EQT, Advent, and KKR. The article also list", "url": "https://www.marketscreener.com/news/qiagen-nv-reduced-to-neutral-by-berenberg-ce7f5edcdf81f520", "source_name": "marketscreener.com", "published_at": "2026-07-14T08:40:38", "published_display": "14 Jul 2026 08:40", "sentiment": "negative", "sentiment_pct": 35, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Berenberg Downgrades Qiagen NV (QGEN) to Hold", "summary": "Berenberg analyst Harry Gillis downgraded Qiagen NV (QGEN) from Buy to Hold. The price target for QGEN was also adjusted to $45.50. This change in rating reflects a revised outlook from the analyst for the company.", "url": "https://www.streetinsider.com/Analyst+Comments/Berenberg+Downgrades+Qiagen+NV+%28QGEN%29+to+Hold/26763718.html", "source_name": "StreetInsider", "published_at": "2026-07-14T07:40:38", "published_display": "14 Jul 2026 07:40", "sentiment": "negative", "sentiment_pct": 30, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Qiagen (QGEN) A Bargain After Takeover Interest Reignited Valuation Questions?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-14T02:43:47+00:00", "published_display": "14 Jul 2026 02:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. (NYSE:QGEN) Given Consensus Rating of \"Hold\" by Analysts", "summary": "Analysts have given Qiagen N.V. (NYSE:QGEN) a consensus \"Hold\" rating based on reports from thirteen research firms, with an average 12-month price target of approximately $43.15. The company recently reported quarterly earnings of $0.54 per share, meeting expectations, and incre", "url": "https://www.marketbeat.com/instant-alerts/qiagen-nv-nyseqgen-given-consensus-rating-of-hold-by-analysts-2026-07-13/", "source_name": "MarketBeat", "published_at": "2026-07-13T08:26:36", "published_display": "13 Jul 2026 08:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arbejdsmarkedets Tillaegspension Raises Holdings in Qiagen N.V. $QGEN", "summary": "Arbejdsmarkedets Tillaegspension increased its stake in Qiagen N.V. by 24.8% in the first quarter, bringing its total holdings to 636,918 shares valued at approximately $25.5 million. Other institutional investors also raised or initiated positions, with hedge funds now owning ab", "url": "https://www.marketbeat.com/instant-alerts/filing-arbejdsmarkedets-tillaegspension-raises-holdings-in-qiagen-nv-qgen-2026-07-13/", "source_name": "MarketBeat", "published_at": "2026-07-13T08:10:36", "published_display": "13 Jul 2026 08:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock holds steady as diagnostics demand supports long-term growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQYXRxTGlQaFZybjJ5a2J0WHl5bXp5QTRPMS1vTG5XVUoyU3Z4ZlRiSnUtRTQ2TWF4dG9FSzkwYmRYcnhDZUFqXzVuSTdFVEg1eVU0TXBNS2k0V2xEdm9MR3lzNTlCMzN3UEpMNmppZTlfbEZRWGloRm84VjllY0dtTUNMM3pCZFdyVUlPaS1saXdOOU1OVzVDa29zRURQZXlsRVZ6M3pITWVVSmVyQXZpSXIwWGxyaWxQZ1VNRTgwRGo4RndMZEE2MERVZlQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-13T06:08:44+00:00", "published_display": "13 Jul 2026 06:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen's Automation Pipeline: A Hidden Catalyst for a 2027 Rebound", "summary": "Despite a recent revenue miss and a cut to its 2026 financial outlook due to near-term challenges, Qiagen is aggressively pursuing a multi-pronged automation strategy with new sample preparation instruments and an expanded digital PCR portfolio slated for 2025-2026 launches. Thes", "url": "https://www.kavout.com/market-lens/qiagen-s-automation-pipeline-a-hidden-catalyst-for-a-2027-rebound", "source_name": "Kavout | AI", "published_at": "2026-07-12T21:10:36", "published_display": "12 Jul 2026 21:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock reflects steady diagnostics demand as investors weigh long-term growth drivers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOT0p5UGpYTGw0d1loeEdBbndGeFltLXVyMWdtWFl1eXYydnhXancxcnpWMUJvN3Y0RWxFTmljekw4b3BERndMUUduUW8xQUY3TktkRV9TOS1PcHJmaFNrV01pVWkzQzJJbG9fWjhUN0FDS2Vqa3JmenB2ellkUHZiMl9DRkJBbUNKcm85RndRd2tkU1dMLU5rRl9CNVZPQ1p6T1VkOF9OTEZoVDJKNi0xVDRjajNXVTA0eFVVY0RrWXQwS2M?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-12T12:19:06+00:00", "published_display": "12 Jul 2026 12:19", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen Stock: New Launches Signal A Turnaround (NYSE:QGEN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNV3RxSmlZOGd2ZkhFR191NFJNTUhla19LejcxN0VRZXd0OVE0elEweTNSMy1SeGJFWkoyYXRTdzFEUGdqMGxKekFGeW5nd1F2NVE2ME5QWC1iQzlURmprVlpYUUZpRzBCUEVHaW1iWk4tbkNGVFgwYk9uMUIxSjVIZXVNZUpKNFE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-12T09:08:39+00:00", "published_display": "12 Jul 2026 09:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Y Intercept Hong Kong Ltd Buys Shares of 34,485 Qiagen N.V. $QGEN", "summary": "Y Intercept Hong Kong Ltd initiated a new position in Qiagen N.V. during the first quarter, acquiring 34,485 shares valued at approximately $1.38 million. Qiagen, which has seen other institutional investors also adjust their holdings, holds a consensus \"Hold\" rating from analyst", "url": "https://www.marketbeat.com/instant-alerts/filing-y-intercept-hong-kong-ltd-buys-shares-of-34485-qiagen-nv-qgen-2026-07-11/", "source_name": "MarketBeat", "published_at": "2026-07-11T15:39:41", "published_display": "11 Jul 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Waterfront Wealth Inc. Makes New $1.05 Million Investment in Qiagen N.V. $QGEN", "summary": "Waterfront Wealth Inc. has made a new $1.05 million investment in Qiagen N.V. during the first quarter, acquiring 26,221 shares. Other institutional investors have also increased their stakes, bringing the total institutional ownership to 70%. Qiagen recently reported an EPS of $", "url": "https://www.marketbeat.com/instant-alerts/filing-waterfront-wealth-inc-makes-new-105-million-investment-in-qiagen-nv-qgen-2026-07-11/", "source_name": "MarketBeat", "published_at": "2026-07-11T14:39:41", "published_display": "11 Jul 2026 14:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG", "summary": "QIAGEN N.V. announced a release regarding voting rights according to Article 40, Section 1 of the WpHG, following a notification from the Netherlands Authority For the Financial Markets (AFM). The notification indicates that Millennium International Management LP holds approximat", "url": "https://www.tradingview.com/news/reuters.com,2026-07-10:newsml_PexWYLhZa:0-pta-pvr-qiagen-n-v-release-according-to-article-40-section-1-of-the-wphg/", "source_name": "TradingView", "published_at": "2026-07-11T08:41:02", "published_display": "11 Jul 2026 08:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of QIAGEN NV \u2013 AQUISEU:QIAD", "summary": "This article provides financial data for QIAGEN NV (QIAD) on the Aquis Stock Exchange, specifically focusing on its enterprise value to revenue forward. The content is sparse, mainly showing the financial metric's period, value, and change, without further analysis or context.", "url": "https://www.tradingview.com/symbols/AQUISEU-QIAD/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-11T05:11:00", "published_display": "11 Jul 2026 05:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen (QGEN) Takeover Talk Puts Valuation Back In Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNeUJNTXE4SVpNVGFWY1Uwb1ZwR0ZLMno3S09LRk1CMTE5R3Y2Q1F2cjhxaTViaEVOYzhUeTg1ZjV0VTYyWUlHQXhKZURsby05VDFtaHowa1kyYk15c0dkbFdvMHo2ZFlsc3Z4T0Robl9fY0UyeVFoMWFPcEhueVZXNzVxaXFGbmJiMU9taDVOUi1yT1pQY2dnVFFEYw?oc=5", "source_name": "Market source", "published_at": "2026-07-11T00:16:00+00:00", "published_display": "11 Jul 2026 00:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen (QGEN) Stock May Be 23% Below Fair Value Despite Takeover Interest", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPX2FxQmRxREtObGJiYWh0V0piVU1PZllYaU1JTnRMaXJqczFDazh0TTd4SnBxVW9hdnhtd0dNWHJFZ2xwZnlNMlkyZEZBQmtjeWNLSDhmTnY3QW9sMDV1eEZ1anBReUVMTnlUWVp0N1ZrMXBtS2F3MFpRREFuNUJUSUJtTjRlZTRuXzlkcENIRFV2Yzg?oc=5", "source_name": "Market source", "published_at": "2026-07-10T02:12:00+00:00", "published_display": "10 Jul 2026 02:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen NV (QGEN) Stock Up 10.5% and Still Undervalued -- GF Scor", "summary": "Qiagen NV (QGEN) saw its stock rise by 10.5% to $41.99, yet GuruFocus's GF Value\u2122 suggests it remains \"Modestly Undervalued\" with a fair value of $52.67. The company boasts an above-average GF Score\u2122 of 69/100, driven by strong valuation and profitability, despite concerns regard", "url": "https://www.gurufocus.com/news/8952598/qiagen-nv-qgen-stock-up-105-and-still-undervalued-gf-score-69100", "source_name": "GuruFocus", "published_at": "2026-07-09T22:41:26", "published_display": "09 Jul 2026 22:41", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QIAGEN Rallies on Renewed Takeover Interest", "summary": "QIAGEN's stock rallied significant interest following reports of renewed takeover bids. This resurgence in acquisition talks indicates strong market confidence in the biotechnology company's value. The potential for a buyout is driving investor optimism and increasing the company", "url": "https://www.moomoo.com/news/post/72746840/qiagen-rallies-on-renewed-takeover-interest", "source_name": "Moomoo", "published_at": "2026-07-09T20:39:41", "published_display": "09 Jul 2026 20:39", "sentiment": "positive", "sentiment_pct": 76, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Market Chatter: Private Equity Firms Reportedly Circle Molecular Testing Company Qiagen", "summary": "Private equity firms are reportedly interested in acquiring Qiagen, a molecular testing company, causing its stock (QGEN) to rise by 10.50%. This news briefly mentions Unity Software's Q4 earnings, where revenue increased 35% year-over-year to $609 million, beating estimates, des", "url": "https://www.moomoo.com/news/post/72727601/market-chatter-private-equity-firms-reportedly-circle-molecular-testing-company?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-09T16:41:26", "published_display": "09 Jul 2026 16:41", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen (NYSE:QGEN) Sees Unusually-High Trading Volume - Still a Buy?", "summary": "Qiagen (NYSE:QGEN) experienced unusually high trading volume, with shares jumping", "url": "https://www.marketbeat.com/instant-alerts/qiagen-nyseqgen-sees-unusually-high-trading-volume-still-a-buy-2026-07-09/", "source_name": "MarketBeat", "published_at": "2026-07-09T16:41:26", "published_display": "09 Jul 2026 16:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EQT, Advent, KKR explore takeover of diagnostics firm Qiagen, Bloomberg News reports", "summary": "Diagnostics company Qiagen is reportedly attracting takeover interest from buyout firms EQT, Advent, and KKR, with potential offers of at least $50 per share. Qiagen's shares rose substantially on the news, although no final decisions have been made. The report follows earlier ne", "url": "https://www.reuters.com/business/qiagen-draws-early-takeover-interest-eqt-advent-kkr-bloomberg-news-reports-2026-07-09/", "source_name": "Reuters", "published_at": "2026-07-09T16:21:42", "published_display": "09 Jul 2026 16:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen Shares Jump on Report of Takeover Interest from EQT, Advent, KKR", "summary": "Qiagen N.V. (NYSE: QGEN) saw its shares climb approximately 11% following reports that private equity firms, including EQT AB, Advent, and KKR, have expressed early takeover interest. The molecular diagnostics company, which maintains a significant presence in Germantown, Marylan", "url": "https://www.citybiz.co/article/872325/qiagen-shares-jump-on-report-of-takeover-interest-from-eqt-advent-kkr/", "source_name": "citybiz", "published_at": "2026-07-09T16:21:41", "published_display": "09 Jul 2026 16:21", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen draws early takeover interest from EQT, Advent & KKR, Bloomberg News reports", "summary": "Diagnostics company Qiagen is reportedly attracting takeover interest from buyout firms including EQT AB, Advent, and KKR, with potential offers reaching at least $50 per share. This news, initially reported by Bloomberg, caused Qiagen's shares in Frankfurt to rise by at least 10", "url": "https://srnnews.com/qiagen-draws-early-takeover-interest-from-eqt-advent-kkr-bloomberg-news-reports/", "source_name": "SRN News", "published_at": "2026-07-09T15:21:42", "published_display": "09 Jul 2026 15:21", "sentiment": "positive", "sentiment_pct": 81, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investors Purchase High Volume of Qiagen Call Options (NYSE:QGEN)", "summary": "Investors recently purchased a high volume of call options for Qiagen (NYSE:QGEN), with Thursday seeing 4,493 calls bought, representing a 261% increase over the average. This unusual options activity coincided with a 12.5% jump in the stock price to $42.75 on heavy trading volum", "url": "https://www.marketbeat.com/instant-alerts/investors-purchase-high-volume-of-qiagen-call-options-nyseqgen-2026-07-09/", "source_name": "MarketBeat", "published_at": "2026-07-09T15:21:42", "published_display": "09 Jul 2026 15:21", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen NV (QGEN) Shares Surge 11% on Potential Buyout Interest", "summary": "Qiagen NV (QGEN) saw its shares surge 11% after reports surfaced about potential acquisition interest from private equity firms, including EQT AB and Advent, with KKR also considering a bid. The company's strong financial health (Altman Z-score of 3.46) and solid profitability (o", "url": "https://www.gurufocus.com/news/8951722/qiagen-nv-qgen-shares-surge-11-on-potential-buyout-interest", "source_name": "GuruFocus", "published_at": "2026-07-09T15:21:41", "published_display": "09 Jul 2026 15:21", "sentiment": "positive", "sentiment_pct": 82, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock jumps on reported takeover interest from buyout firms By Investing.com", "summary": "Qiagen NV (NYSE:QGEN) shares rose 9% after Bloomberg reported that private equity firms, including EQT AB and Advent, are showing early takeover interest in the European molecular testing company. KKR & Co. is also among the firms expressing interest. The company's shares have fa", "url": "https://m.za.investing.com/news/stock-market-news/qiagen-stock-jumps-on-reported-takeover-interest-from-buyout-firms-93CH-4362972?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-07-09T14:21:42", "published_display": "09 Jul 2026 14:21", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen jumps after report of takeover interest from EQT, Advent", "summary": "Qiagen N.V. (QGEN) saw its stock jump 11% following reports of early takeover interest from private equity firms. EQT AB and Advent are among the firms showing interest in the European molecular testing company, with KKR also mentioned as a potential financial buyer.", "url": "https://seekingalpha.com/news/4612678-qiagen-jumps-after-report-of-takeover-interest-fomr-eqt-advent", "source_name": "Seeking Alpha", "published_at": "2026-07-09T10:31:00", "published_display": "09 Jul 2026 10:31", "sentiment": "positive", "sentiment_pct": 81, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock jumps on reported takeover interest from buyout firms", "summary": "Qiagen NV shares rose 9% after Bloomberg reported that the European molecular testing company is attracting early takeover interest from private equity firms, including EQT AB and Advent, with KKR & Co. also expressing interest. The company, which has seen its shares fall 16% in ", "url": "https://www.investing.com/news/stock-market-news/qiagen-stock-jumps-on-reported-takeover-interest-from-buyout-firms-93CH-4784448", "source_name": "Investing.com", "published_at": "2026-07-09T10:30:00", "published_display": "09 Jul 2026 10:30", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. highlights its diagnostics platform as investors watch global health demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQM2x6X05yM09Wbmk5UXlPU1E3ejlPSVpDNU9kYUw2QlNzc000LXlNM2RieTBXOWdXbFFuRFpaa0EzTDh6ZURudHlxNENhRGdwdVhfcGJnSm9MaElXT21YeXVyOW51SXFvV0pOejFfelZBLTdmanExUVZXRERuVDNQaVZGdWg3RWI4ZURHQ21sMFZQcWR1TXBxdnVMMVk4LTBjYXdWOXBGMFZSMWc3eDB3dHpvU09jNllwTFlhSDhVcFB2cXJUQTFtNGdDRQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T09:16:08+00:00", "published_display": "09 Jul 2026 09:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. builds on diagnostics demand as investors track global healthcare trends", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOektEcWtFUzNWaE1XZ2dUQlNKdnpiN3ZiTkwzUzFIVE9ubU5RQlZPelEtOEphTmJNWW9fNkEyVGVXaDQyRW5MYmVJVDRNODNTQU1id1hLRm5OWi1McS1rNml4VGhCYmR0bmZ4UHN3QTRKbnZ5UGg0WEIzZHc1NXlISG5NTWJYZGVhSGstTDFRamdVWEpJZWhHR2tRNmk1bDlwSWpUUDdmSTN6eUl0NmxtTEtva1lVUGppUFVlZ1ZHZDB1dw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T05:06:29+00:00", "published_display": "09 Jul 2026 05:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. focuses on diagnostics growth and US exposure", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNZ2lQX0k4cl9wZ1hTYmVSNTdZZmhMcllCMG1YUEc0c1dTMzhnZmJqZWNubXZaeWFZVmx0WjdWbGNuUzBLcEtVVmVSSmN0OXF4UjdRUkFNNEE5Q3FBM002ZU9VWmFCTktPNWl4ZFFPNkZTWTlEbVIxUDNMMTMtU256SjRkQ3kxQlN0RFRLVm5KWklUSWVGNE5Hd09qbjFwSUthMnNUbUNRSEdQdjF1QzlqN1JjbVNWUQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-07T06:18:50+00:00", "published_display": "07 Jul 2026 06:18", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. highlights molecular diagnostics growth as investors eye global health demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOQko3MXlYWXFwTHkxSnMxOV9tY1VOWVJqOFpMc2JTYS1LU191dDgzWUM4Rnp1MGNGSVBsSW50OGs4SU1maVVDcHZ1aUg3TVF6Y1hheUNlVjU4cHBqRWl3dk5lRHYtb01xSWRocm9HSFVObUFsd2RjeE5KRHVtWElaMzhvcDBwdW9pX1BzcTBuTXNwYmhzMmVsaWE5eFEwWDFoekxXQVo1Skw4aXJoS1YwQWpSMnZHQkJ4RG90YnVyZFVWa0J5?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-06T06:41:22+00:00", "published_display": "06 Jul 2026 06:41", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors Are Reacting To Qiagen (QGEN) Joining The Russell 1000 Dynamic Index", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNT0hDZWxqZ0x4dlZqZ0NLYm5CdVdkeXVVVTRjUk12S25nX3VTbGc5QktCaTdwbnl0WjVGdFhOMG9HYXh1eW5JYUVpYmJMVUhEQ190MDNlWWtoS053eU5talpsR2psZ19tTFZwVnozekxXdF9DTlpVV3ozYnJudU12TmhMRHg2S2FWR19ucUR3M0prdjJTRVY1d3NNaTlDMHRRbTYzWXUydWp5WWYtMGdyd2JYWlpaT0RNb3dqMmFrTTh0b2NxdDRQSFRicUgtdEJ0MTFLSNIB2gFBVV95cUxOdWk0WDFFQzV3ZGNhR3Z4VnRQVDhidEhkU3pTbC1tZ3VqTFpxMTdXbXFVcWs2TXgtRm9GdThvT1BoNS1tMHRTc3lzVngwN2pHcTNiZEdZNFRpV21FYUtUMXBoQ01ZcHMtRTNFOXlEZE03b2NsWTdJT0R5NldEeWF4WjgyR1Z5bFB5U3hTQ1dtNFdhbEYyLTJmNGx1TVJIU0tkaERJeFEzVTJ6NE1xNWVNYjZlM0hfajcwcjRRZWNpRWk1aFZSVXBsa3BoWHY4cTRMT0JOZjlNQ08yZw?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T13:31:12+00:00", "published_display": "05 Jul 2026 13:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. updates earnings calendar, shares tracked against diagnostics peers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOUTNqbEpUTW4xd3RUTE5nMEt0ZEJFT25xZVBoYjRYYk56b18xdkwyWFJncVR1cjMwa25pbUhudWk2Ukk5RlBqLU1fRXo5YmZXNlZQMG5ubnExM1o4YXZpSDE3enY4T0MtLTVIS1dnYUlVWTZMNW5HVkFKNVFFbFZRVnQ3Z0ZkNnJmN0NMRHVRZXJtQkw2b1RUazZSZW1yaTVCM0VVYU9RM1o3YWF4MHlZM2ppSWZnekVxUEN4Y01GaWRiUXVTMHE0bXRB?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-26T05:11:57+00:00", "published_display": "26 Jun 2026 05:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen Stock - Friday review and sector comparison", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPMnFsVUVVSFdZT0FrVzRrWDNLN0RiU1U4dG85Nk91amg0X0Mxa1psR1pBb2gzT2dONnl4QU04MkdVVFh6eHYzSGN5MGpndktlSU9uSlZUUDZUY3JDal80RG94OHNtUDEwMWhRa3hBWmNQaV9YXzc4WFVuWVlMTE93Y19iSjd1Um8ycmh6a1BnUXgzZnRBR0w0TWdQTG9wWGNFS1F4ZWQtOC1QMmM?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. Stock (NL0012169213): Analyst Views And Fundamentals In Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPWk5RdUxoR0ZERTVybUUtWmJGMWdpOG1FbEdySG5XRGVCLTVzdHQwMU5XQjBzQW10YjI3bklqNTN2NlRGVGlwaTNtbFVrRVlWU1dIX1hEeVRMS2owZUNrUU1ybDFMU1JjV2oyeHBkdjVmYk55MmZLcjQ2c0s3ME9PWVA3VWQ2ckRBQ0E5WUpQYjdYM3g2dVJ5cmsySXZQTzhmRDdXSzVwUlVaZ2JveGRyQ3ZGdC1veHFIWWMySFFxOE55REx2RDFB?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-16T19:49:10+00:00", "published_display": "16 Jun 2026 19:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. stock (NL0012169213): UBS stake disclosure and AFM voting rights notice keep insider own", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNTDhuR1BYazZuTVY3MEo5bjRvbXdjUnpJak9CeFJsbnktc0NZUTlQemhNYlVYdldYVWhvcFB5V3NWX2FHWlhLT1NKckdiZzlEODZ4MS1kZVRYdkpTUTRYVUtjNXBPQnliNmpLb3E0VjUtMndmVllPbW8yc05RNWxleF8tdVdDcHBuR1ZYMmNTYm9MUHcwMGp2V2xfdTJRM1pNOWJjUDhXVTB2VDZ2NnRoejd6MVI1QXM1ZmktcDlqVXBKZw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-30T07:00:00+00:00", "published_display": "30 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New QIAGEN AI lab assistant is designed to speed experiment planning", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNSkEtd2lYQUdodm5QZW9nYVh6Mkk5SGM1WFQyTXNSR3hZTXhNZHRmODBBMTZZeF9wNGtlUTJKMURrYWY3N3FKN1ZOb3VUR1pMejY5VWMtMUZPanQyMUtxNzRLV0RkQTVTZDZFcTBQWU5zVzRocDExMC1nVkFCRnhZeHhSdDN6Q3JYSGQzeWVtbkJaTDJRRzlMbzg5MlZuaUcwbXhfSFJYVVM3NU1MMUJfOWg3NllIRGRxa3BVXzNB?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird upgrades Qiagen stock rating on valuation after pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQZHl2RUhhMnVpVXdDOFptU1JxUlRMLWFtZm9HMTJzZFJ0ZE1UVElwSTBycTY3emZiUjNCVVRXNXloMnB2ejhNS0w5UGRiUnZlZlQxdmFZS1pEZUNabkxqMEZiS0wtYld3T2FYNm5EMjhERXNJUTI0TU1XWElIUEZZb1NHLVVUMUlSeXNZd2M0c2FPVTd2Skx3LV8zSFhuN2dYV2FLZ3BJbTFhX1NBckZQS1V6OXVKRXVyWjNkNENKWQ?oc=5", "source_name": "Investing.com", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen NV (QGEN) Falls to 7-Year Low as MidEast Tensions Drag Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQSERuR2FRZWZVOVNZMFRTREI3TUlkVkNqYXhVdS1vMzB6SnkxY0stUEdBS2tlWWZIWGhnQndvQUIyUHdJS2hlRmo4X095ejJhUE1GX0k5VUVDMFpSQTBTMUVtQWhnRnJWSFJMdk43NUtkbE5Zd2pZUHY3VEV6YXdVbDJ4Q28wVWswNktPTU9XYng?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen cuts 2026 outlook on lower immigration testing demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOYVBsbV93NDJtY2kzV05WbW5VYldJMFc0YUtHR3ZsTnRGSUplMFdSMldfYnk2VG5VeUc4cmJFdUNKN2c5TTJ1TlR4bmdYN2JGMGhXT3dVTDhBN2Z4NGN5ekVHa3J6WFIwWTZkU0RsdnozREJpb3duWkI1bHgxWU9hR2FhLWs4OVZxUV9OcnhOLUZrS0d3RW1Ta3ZHOXBhMFpQWHNWNVdlZ0lBYjVOaGJtRTA1ZGp4NjdF?oc=5", "source_name": "Investing.com", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeover rumours at Qiagen fuel share price surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNZlZJR3pRV0g3SDd2LVB5dlNURlpFcWNzU3EwX1RkcVc3WS1pQkprNFkwcW1sNEhOSkZCeG94Z3VkWTZiX09lQ2ZRZU4yanJQSFAwaUZvZlRaR3NielloSnBRM1RhaEJPYVFHcjh0aENEU1NQWThFNVozMVZjT2pXSXpRcnFzaEFyVGN5dFVSdE1DUkFKR2phdkdqMHQ0QQ?oc=5", "source_name": "European Biotechnology Magazine", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Have Qiagen Insiders Been Selling Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOSnVkSVBYZlFoZ2MyYjZoM01DMFczaHo2bzBBZjQyT0lQZjNHSHlaNDlMMHdHZTFFWXp6TFl3NzN4UzNDV3BfS1ZtUTBRb1BHVF9PSXB4eGxTM0lacFk2TVl5Sjl6OXV4YS11Z3FvVURzUnJHUWg5Tlc5VV93QU82cExXZ21KRl8tT1JBWE9pSDM0ZFBiME1mV2V4cEotNGl2blp4V2xWLTN1eUNJV3RkZENUWTJhY25p0gG-AUFVX3lxTFBxUW5nU29EVlBFQkVOVTUyNW1BYUZBS2czWURuaDZieVRVYUxrZEdsbHJaZkNRV042dHBYOEsyZ2pKQUI3YnpXM18xV3k2MUNhRmRiUXlfZWlUNTJ4ZEFXN0FGUDNNZ0VBX3ZOOWFUYXBLa3F0NEwzUnRtWnpPNm0tOFBiUGpiSmdyRVUtR0Ztci12OXA2V0YzMktUWk1KaWxIZXBYM0lFT3pvTlhoSVRPbl9BVzZzRU9vRFFYTEE?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-23T07:00:00+00:00", "published_display": "23 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Qiagen highlights testing tools amid U.S. cyclosporiasis outbreak By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQeDkyQ25HTk1sVzg2c2RJSExjMzlJTm9IeXEwN2tZNjFJV2NiWlFva1FFb3dvTmZqc1ZiMFNhSl9VQ1IzY1ZIVkhiMnlpeUJmODl2c3dFNFlxR3F3N0pHNmx3Z3JwM0NadkwyMlJNaVJXVWNvRm5vQ2RyNnZsMmJmZEZCNk1aZ1ZNTEJmUGlvdEJwOW5PRTEtWTVDN1loXy1PTGhuUUk1Tng5ZFV5SVIxNC1CMGVWS05ya0w0S3lITGNVZDBSaElXdHd5aXlLdXAweFE?oc=5", "source_name": "Investing.com India", "published_at": "2026-07-15T23:19:25+00:00", "published_display": "15 Jul 2026 23:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QIAGEN Highlights Molecular Testing Solutions Supporting Response to Growing U.S. Cyclospora Outbreak", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/qiagen-highlights-molecular-testing-solutions-200500903.html", "source_name": "Business Wire", "published_at": "2026-07-15T20:05:00+00:00", "published_display": "15 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Over 1,600 U.S. Cyclospora Cases; QIAGEN Test Takes an Hour", "summary": "QIAGEN (QGEN) has highlighted its molecular testing solutions for the growing number of cyclosporiasis cases in the U.S., with over 1,600 confirmed infections since May 2026. The company's FDA-cleared QIAstat-Dx Gastrointestinal Panel 2 can detect Cyclospora in about an hour as p", "url": "https://www.stocktitan.net/news/QGEN/qiagen-highlights-molecular-testing-solutions-supporting-response-to-bx81opg7eixm.html", "source_name": "Stock Titan", "published_at": "2026-07-15T19:41:58", "published_display": "15 Jul 2026 19:41", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QIAGEN sets August 6 webcast for second-quarter results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOOHlYeUhfLVozM05NLTZGU00yZWdJM0NfQ0xwQ1E0Q1djcGN2enM2M2VqRDVxbmtILWV6NkNIeDRPRGZlTVJLVERPZ24zLXdwVXBrTmhLaGpYLXRMUVAxYmRHZjJlVGtlTGF0R2pvZWVtdzZaMU1uNnNZSEZhVF9PWmFkUGlEb1pSVnZhNW12Y2xNRWIwbng1b0wyXzFRUHEtdl9tT0xvbFI?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T12:50:50+00:00", "published_display": "15 Jul 2026 12:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Berenberg Downgrades Qiagen Rating, Price Target Amid Rising Competition, Growth Concerns", "summary": "Berenberg has downgraded Qiagen's rating and reduced its price target, citing increasing competition and decelerating growth potential. This adjustment comes as the analytical instruments and consumables market faces new challenges. Investors will be watching how Qiagen responds ", "url": "https://www.moomoo.com/news/post/73001950/berenberg-downgrades-qiagen-rating-price-target-amid-rising-competition-growth", "source_name": "Moomoo", "published_at": "2026-07-15T13:41:58", "published_display": "15 Jul 2026 13:41", "sentiment": "negative", "sentiment_pct": 28, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QIAGEN N.V. to Release Results for Q2 2026 and Hold Webcast", "summary": "QIAGEN N.V. announced its plans to release second-quarter 2026 financial results on Wednesday, August 5, 2026, followed by a conference call on Thursday, August 6, 2026. Interested parties can access the call via callback connection, dial-in numbers, or a live audio webcast, and ", "url": "https://www.businesswire.com/news/home/20260715523254/en/QIAGEN-N.V.-to-Release-Results-for-Q2-2026-and-Hold-Webcast", "source_name": "Business Wire", "published_at": "2026-07-15T12:41:58", "published_display": "15 Jul 2026 12:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QIAGEN Expands QIAstat-Dx Bloodstream Infection Testing Menu in Europe", "summary": "QIAGEN has launched the CE-IVDR-certified QIAstat-Dx BCID GN Plus AMR Panel in Europe, significantly expanding its bloodstream infection testing capabilities. This new panel, alongside an existing one, can detect 33 pathogen targets and 28 antimicrobial resistance markers from po", "url": "https://www.biospace.com/press-releases/qiagen-expands-qiastat-dx-bloodstream-infection-testing-menu-in-europe", "source_name": "BioSpace", "published_at": "2026-07-15T05:41:36", "published_display": "15 Jul 2026 05:41", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Qiagen N.V. \u2013 NYSE:QGEN", "summary": "This article focuses on the enterprise value to revenue forward metric for Qiagen N.V. (NYSE: QGEN). It appears to be a financial data point presented on TradingView's platform, indicating a specific period and value for this financial ratio. The content itself seems to be a data", "url": "https://www.tradingview.com/symbols/NYSE-QGEN/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-15T00:41:36", "published_display": "15 Jul 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen Launches QIAstat-Dx Bloodstream Infection Testing in Europe", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/qiagen-launches-qiastat-dx-bloodstream-213136270.html", "source_name": "MT Newswires", "published_at": "2026-07-14T21:31:36+00:00", "published_display": "14 Jul 2026 21:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen launches bloodstream infection test panel in Europe By Investing.com", "summary": "QIAGEN N.V. (NYSE:QGEN) has launched its CE-IVDR-certified QIAstat-Dx BCID GN Plus AMR Panel in Europe for bloodstream infection testing, capable of detecting gram-negative bacterial pathogens and antimicrobial resistance markers. This new panel complements an existing one, colle", "url": "https://za.investing.com/news/stock-market-news/qiagen-launches-bloodstream-infection-test-panel-in-europe-93CH-4368823", "source_name": "Investing.com South Africa", "published_at": "2026-07-14T21:41:36", "published_display": "14 Jul 2026 21:41", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New QIAGEN test detects bloodstream pathogens and resistance in about an hour", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOMDZxdk9BMlR6VW1pUXVWSUhtY0dydnpKd295aVdQTXFFOWxJU0ZfNGY1X0JyRU9jUlhTV0hzb1ZDQlJCX2VGazUybHluYzdKNERzSGtPdzF3UVlVMEg2QjhzNVV1azBuOGMzTEVuQXlsNDdVbUVEYVFVckFTZDRUTWpWTkRtZGVsSTZVa2lVajJmalJiTGZvOTJXcnpxdkg1NnFMTEVORnRTbTdEeVdtOTZqYndlaDVybGV3?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T20:07:14+00:00", "published_display": "14 Jul 2026 20:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Berenberg Downgrades QIAGEN to Hold From Buy, Cuts Price Target to $45.50 From $59", "summary": "Berenberg has downgraded QIAGEN (QGEN) stock from Buy to Hold and significantly cut its price target from $59 to $45.50. This change in rating and price target suggests a more cautious outlook from the investment bank regarding QIAGEN's future performance.", "url": "https://www.moomoo.com/news/post/72927908/berenberg-downgrades-qiagen-to-hold-from-buy-cuts-price-target?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-14T11:41:36", "published_display": "14 Jul 2026 11:41", "sentiment": "negative", "sentiment_pct": 28, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock holds steady as diagnostics demand shapes long term outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQelQ5VFNlelhIMTJsZk10QUwxRE5sNFBOdEVJVVdSdHVFaS03NjJTXzE1NUZxNUJVUDB1a1k2VFlpM3IzYjFxX3dkVFg5UkxfRGt1Nl8takZ6Y0NSLWFHRzlIeFFwVnhHYlktNUIzN3JGZlZ6OUxwQlo3T1ZGUVJ4T2tXMnlzUlA1UVpoMFFpVlhxTlZhUTRUVWI2WjZRZHFIRHp4R0MyZE53SWI1Tk9KRmg0T3c2QkhnWEw3dDFXZXFCNTVpdDJJWVBHQQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-14T09:00:58+00:00", "published_display": "14 Jul 2026 09:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Berenberg cuts Qiagen stock rating on competitive pressures", "summary": "Berenberg has downgraded Qiagen NV to Hold from Buy and reduced its price target due to competitive pressures on its QuantiFERON franchise and weakening expectations for U.S. life sciences research spending. Despite a new buyback program and the stock appearing slightly undervalu", "url": "https://www.investing.com/news/analyst-ratings/berenberg-cuts-qiagen-stock-rating-on-competitive-pressures-93CH-4789883", "source_name": "Investing.com", "published_at": "2026-07-14T08:52:38", "published_display": "14 Jul 2026 08:52", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Berenberg downgrades Qiagen stock rating on competitive concerns", "summary": "Berenberg downgraded Qiagen NV's stock rating from Buy to Hold and lowered its price target due to concerns about the deterioration of its outlook in the first half of 2026 and increasing competitive pressure for its QuantiFERON franchise. The firm cited lower immigration demand ", "url": "https://www.investing.com/news/analyst-ratings/berenberg-downgrades-qiagen-stock-rating-on-competitive-concerns-93CH-4789902", "source_name": "Investing.com", "published_at": "2026-07-14T08:52:38", "published_display": "14 Jul 2026 08:52", "sentiment": "negative", "sentiment_pct": 32, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QIAGEN NV : Reduced to Neutral by Berenberg", "summary": "Berenberg has downgraded its recommendation for QIAGEN NV to Neutral, lowering the target price from EUR 50 to EUR 40. This revision comes amidst recent news regarding potential takeover interest in Qiagen from private equity firms like EQT, Advent, and KKR. The article also list", "url": "https://www.marketscreener.com/news/qiagen-nv-reduced-to-neutral-by-berenberg-ce7f5edcdf81f520", "source_name": "marketscreener.com", "published_at": "2026-07-14T08:40:38", "published_display": "14 Jul 2026 08:40", "sentiment": "negative", "sentiment_pct": 35, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Berenberg Downgrades Qiagen NV (QGEN) to Hold", "summary": "Berenberg analyst Harry Gillis downgraded Qiagen NV (QGEN) from Buy to Hold. The price target for QGEN was also adjusted to $45.50. This change in rating reflects a revised outlook from the analyst for the company.", "url": "https://www.streetinsider.com/Analyst+Comments/Berenberg+Downgrades+Qiagen+NV+%28QGEN%29+to+Hold/26763718.html", "source_name": "StreetInsider", "published_at": "2026-07-14T07:40:38", "published_display": "14 Jul 2026 07:40", "sentiment": "negative", "sentiment_pct": 30, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Qiagen (QGEN) A Bargain After Takeover Interest Reignited Valuation Questions?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-14T02:43:47+00:00", "published_display": "14 Jul 2026 02:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. (NYSE:QGEN) Given Consensus Rating of \"Hold\" by Analysts", "summary": "Analysts have given Qiagen N.V. (NYSE:QGEN) a consensus \"Hold\" rating based on reports from thirteen research firms, with an average 12-month price target of approximately $43.15. The company recently reported quarterly earnings of $0.54 per share, meeting expectations, and incre", "url": "https://www.marketbeat.com/instant-alerts/qiagen-nv-nyseqgen-given-consensus-rating-of-hold-by-analysts-2026-07-13/", "source_name": "MarketBeat", "published_at": "2026-07-13T08:26:36", "published_display": "13 Jul 2026 08:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Arbejdsmarkedets Tillaegspension Raises Holdings in Qiagen N.V. $QGEN", "summary": "Arbejdsmarkedets Tillaegspension increased its stake in Qiagen N.V. by 24.8% in the first quarter, bringing its total holdings to 636,918 shares valued at approximately $25.5 million. Other institutional investors also raised or initiated positions, with hedge funds now owning ab", "url": "https://www.marketbeat.com/instant-alerts/filing-arbejdsmarkedets-tillaegspension-raises-holdings-in-qiagen-nv-qgen-2026-07-13/", "source_name": "MarketBeat", "published_at": "2026-07-13T08:10:36", "published_display": "13 Jul 2026 08:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock holds steady as diagnostics demand supports long-term growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQYXRxTGlQaFZybjJ5a2J0WHl5bXp5QTRPMS1vTG5XVUoyU3Z4ZlRiSnUtRTQ2TWF4dG9FSzkwYmRYcnhDZUFqXzVuSTdFVEg1eVU0TXBNS2k0V2xEdm9MR3lzNTlCMzN3UEpMNmppZTlfbEZRWGloRm84VjllY0dtTUNMM3pCZFdyVUlPaS1saXdOOU1OVzVDa29zRURQZXlsRVZ6M3pITWVVSmVyQXZpSXIwWGxyaWxQZ1VNRTgwRGo4RndMZEE2MERVZlQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-13T06:08:44+00:00", "published_display": "13 Jul 2026 06:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen's Automation Pipeline: A Hidden Catalyst for a 2027 Rebound", "summary": "Despite a recent revenue miss and a cut to its 2026 financial outlook due to near-term challenges, Qiagen is aggressively pursuing a multi-pronged automation strategy with new sample preparation instruments and an expanded digital PCR portfolio slated for 2025-2026 launches. Thes", "url": "https://www.kavout.com/market-lens/qiagen-s-automation-pipeline-a-hidden-catalyst-for-a-2027-rebound", "source_name": "Kavout | AI", "published_at": "2026-07-12T21:10:36", "published_display": "12 Jul 2026 21:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock reflects steady diagnostics demand as investors weigh long-term growth drivers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOT0p5UGpYTGw0d1loeEdBbndGeFltLXVyMWdtWFl1eXYydnhXancxcnpWMUJvN3Y0RWxFTmljekw4b3BERndMUUduUW8xQUY3TktkRV9TOS1PcHJmaFNrV01pVWkzQzJJbG9fWjhUN0FDS2Vqa3JmenB2ellkUHZiMl9DRkJBbUNKcm85RndRd2tkU1dMLU5rRl9CNVZPQ1p6T1VkOF9OTEZoVDJKNi0xVDRjajNXVTA0eFVVY0RrWXQwS2M?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-12T12:19:06+00:00", "published_display": "12 Jul 2026 12:19", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen Stock: New Launches Signal A Turnaround (NYSE:QGEN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNV3RxSmlZOGd2ZkhFR191NFJNTUhla19LejcxN0VRZXd0OVE0elEweTNSMy1SeGJFWkoyYXRTdzFEUGdqMGxKekFGeW5nd1F2NVE2ME5QWC1iQzlURmprVlpYUUZpRzBCUEVHaW1iWk4tbkNGVFgwYk9uMUIxSjVIZXVNZUpKNFE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-12T09:08:39+00:00", "published_display": "12 Jul 2026 09:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Y Intercept Hong Kong Ltd Buys Shares of 34,485 Qiagen N.V. $QGEN", "summary": "Y Intercept Hong Kong Ltd initiated a new position in Qiagen N.V. during the first quarter, acquiring 34,485 shares valued at approximately $1.38 million. Qiagen, which has seen other institutional investors also adjust their holdings, holds a consensus \"Hold\" rating from analyst", "url": "https://www.marketbeat.com/instant-alerts/filing-y-intercept-hong-kong-ltd-buys-shares-of-34485-qiagen-nv-qgen-2026-07-11/", "source_name": "MarketBeat", "published_at": "2026-07-11T15:39:41", "published_display": "11 Jul 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Waterfront Wealth Inc. Makes New $1.05 Million Investment in Qiagen N.V. $QGEN", "summary": "Waterfront Wealth Inc. has made a new $1.05 million investment in Qiagen N.V. during the first quarter, acquiring 26,221 shares. Other institutional investors have also increased their stakes, bringing the total institutional ownership to 70%. Qiagen recently reported an EPS of $", "url": "https://www.marketbeat.com/instant-alerts/filing-waterfront-wealth-inc-makes-new-105-million-investment-in-qiagen-nv-qgen-2026-07-11/", "source_name": "MarketBeat", "published_at": "2026-07-11T14:39:41", "published_display": "11 Jul 2026 14:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG", "summary": "QIAGEN N.V. announced a release regarding voting rights according to Article 40, Section 1 of the WpHG, following a notification from the Netherlands Authority For the Financial Markets (AFM). The notification indicates that Millennium International Management LP holds approximat", "url": "https://www.tradingview.com/news/reuters.com,2026-07-10:newsml_PexWYLhZa:0-pta-pvr-qiagen-n-v-release-according-to-article-40-section-1-of-the-wphg/", "source_name": "TradingView", "published_at": "2026-07-11T08:41:02", "published_display": "11 Jul 2026 08:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of QIAGEN NV \u2013 AQUISEU:QIAD", "summary": "This article provides financial data for QIAGEN NV (QIAD) on the Aquis Stock Exchange, specifically focusing on its enterprise value to revenue forward. The content is sparse, mainly showing the financial metric's period, value, and change, without further analysis or context.", "url": "https://www.tradingview.com/symbols/AQUISEU-QIAD/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-11T05:11:00", "published_display": "11 Jul 2026 05:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen (QGEN) Takeover Talk Puts Valuation Back In Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNeUJNTXE4SVpNVGFWY1Uwb1ZwR0ZLMno3S09LRk1CMTE5R3Y2Q1F2cjhxaTViaEVOYzhUeTg1ZjV0VTYyWUlHQXhKZURsby05VDFtaHowa1kyYk15c0dkbFdvMHo2ZFlsc3Z4T0Robl9fY0UyeVFoMWFPcEhueVZXNzVxaXFGbmJiMU9taDVOUi1yT1pQY2dnVFFEYw?oc=5", "source_name": "Market source", "published_at": "2026-07-11T00:16:00+00:00", "published_display": "11 Jul 2026 00:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen (QGEN) Stock May Be 23% Below Fair Value Despite Takeover Interest", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPX2FxQmRxREtObGJiYWh0V0piVU1PZllYaU1JTnRMaXJqczFDazh0TTd4SnBxVW9hdnhtd0dNWHJFZ2xwZnlNMlkyZEZBQmtjeWNLSDhmTnY3QW9sMDV1eEZ1anBReUVMTnlUWVp0N1ZrMXBtS2F3MFpRREFuNUJUSUJtTjRlZTRuXzlkcENIRFV2Yzg?oc=5", "source_name": "Market source", "published_at": "2026-07-10T02:12:00+00:00", "published_display": "10 Jul 2026 02:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen NV (QGEN) Stock Up 10.5% and Still Undervalued -- GF Scor", "summary": "Qiagen NV (QGEN) saw its stock rise by 10.5% to $41.99, yet GuruFocus's GF Value\u2122 suggests it remains \"Modestly Undervalued\" with a fair value of $52.67. The company boasts an above-average GF Score\u2122 of 69/100, driven by strong valuation and profitability, despite concerns regard", "url": "https://www.gurufocus.com/news/8952598/qiagen-nv-qgen-stock-up-105-and-still-undervalued-gf-score-69100", "source_name": "GuruFocus", "published_at": "2026-07-09T22:41:26", "published_display": "09 Jul 2026 22:41", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "QIAGEN Rallies on Renewed Takeover Interest", "summary": "QIAGEN's stock rallied significant interest following reports of renewed takeover bids. This resurgence in acquisition talks indicates strong market confidence in the biotechnology company's value. The potential for a buyout is driving investor optimism and increasing the company", "url": "https://www.moomoo.com/news/post/72746840/qiagen-rallies-on-renewed-takeover-interest", "source_name": "Moomoo", "published_at": "2026-07-09T20:39:41", "published_display": "09 Jul 2026 20:39", "sentiment": "positive", "sentiment_pct": 76, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Market Chatter: Private Equity Firms Reportedly Circle Molecular Testing Company Qiagen", "summary": "Private equity firms are reportedly interested in acquiring Qiagen, a molecular testing company, causing its stock (QGEN) to rise by 10.50%. This news briefly mentions Unity Software's Q4 earnings, where revenue increased 35% year-over-year to $609 million, beating estimates, des", "url": "https://www.moomoo.com/news/post/72727601/market-chatter-private-equity-firms-reportedly-circle-molecular-testing-company?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-09T16:41:26", "published_display": "09 Jul 2026 16:41", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen (NYSE:QGEN) Sees Unusually-High Trading Volume - Still a Buy?", "summary": "Qiagen (NYSE:QGEN) experienced unusually high trading volume, with shares jumping", "url": "https://www.marketbeat.com/instant-alerts/qiagen-nyseqgen-sees-unusually-high-trading-volume-still-a-buy-2026-07-09/", "source_name": "MarketBeat", "published_at": "2026-07-09T16:41:26", "published_display": "09 Jul 2026 16:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EQT, Advent, KKR explore takeover of diagnostics firm Qiagen, Bloomberg News reports", "summary": "Diagnostics company Qiagen is reportedly attracting takeover interest from buyout firms EQT, Advent, and KKR, with potential offers of at least $50 per share. Qiagen's shares rose substantially on the news, although no final decisions have been made. The report follows earlier ne", "url": "https://www.reuters.com/business/qiagen-draws-early-takeover-interest-eqt-advent-kkr-bloomberg-news-reports-2026-07-09/", "source_name": "Reuters", "published_at": "2026-07-09T16:21:42", "published_display": "09 Jul 2026 16:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen Shares Jump on Report of Takeover Interest from EQT, Advent, KKR", "summary": "Qiagen N.V. (NYSE: QGEN) saw its shares climb approximately 11% following reports that private equity firms, including EQT AB, Advent, and KKR, have expressed early takeover interest. The molecular diagnostics company, which maintains a significant presence in Germantown, Marylan", "url": "https://www.citybiz.co/article/872325/qiagen-shares-jump-on-report-of-takeover-interest-from-eqt-advent-kkr/", "source_name": "citybiz", "published_at": "2026-07-09T16:21:41", "published_display": "09 Jul 2026 16:21", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen draws early takeover interest from EQT, Advent & KKR, Bloomberg News reports", "summary": "Diagnostics company Qiagen is reportedly attracting takeover interest from buyout firms including EQT AB, Advent, and KKR, with potential offers reaching at least $50 per share. This news, initially reported by Bloomberg, caused Qiagen's shares in Frankfurt to rise by at least 10", "url": "https://srnnews.com/qiagen-draws-early-takeover-interest-from-eqt-advent-kkr-bloomberg-news-reports/", "source_name": "SRN News", "published_at": "2026-07-09T15:21:42", "published_display": "09 Jul 2026 15:21", "sentiment": "positive", "sentiment_pct": 81, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investors Purchase High Volume of Qiagen Call Options (NYSE:QGEN)", "summary": "Investors recently purchased a high volume of call options for Qiagen (NYSE:QGEN), with Thursday seeing 4,493 calls bought, representing a 261% increase over the average. This unusual options activity coincided with a 12.5% jump in the stock price to $42.75 on heavy trading volum", "url": "https://www.marketbeat.com/instant-alerts/investors-purchase-high-volume-of-qiagen-call-options-nyseqgen-2026-07-09/", "source_name": "MarketBeat", "published_at": "2026-07-09T15:21:42", "published_display": "09 Jul 2026 15:21", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen NV (QGEN) Shares Surge 11% on Potential Buyout Interest", "summary": "Qiagen NV (QGEN) saw its shares surge 11% after reports surfaced about potential acquisition interest from private equity firms, including EQT AB and Advent, with KKR also considering a bid. The company's strong financial health (Altman Z-score of 3.46) and solid profitability (o", "url": "https://www.gurufocus.com/news/8951722/qiagen-nv-qgen-shares-surge-11-on-potential-buyout-interest", "source_name": "GuruFocus", "published_at": "2026-07-09T15:21:41", "published_display": "09 Jul 2026 15:21", "sentiment": "positive", "sentiment_pct": 82, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock jumps on reported takeover interest from buyout firms By Investing.com", "summary": "Qiagen NV (NYSE:QGEN) shares rose 9% after Bloomberg reported that private equity firms, including EQT AB and Advent, are showing early takeover interest in the European molecular testing company. KKR & Co. is also among the firms expressing interest. The company's shares have fa", "url": "https://m.za.investing.com/news/stock-market-news/qiagen-stock-jumps-on-reported-takeover-interest-from-buyout-firms-93CH-4362972?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-07-09T14:21:42", "published_display": "09 Jul 2026 14:21", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen jumps after report of takeover interest from EQT, Advent", "summary": "Qiagen N.V. (QGEN) saw its stock jump 11% following reports of early takeover interest from private equity firms. EQT AB and Advent are among the firms showing interest in the European molecular testing company, with KKR also mentioned as a potential financial buyer.", "url": "https://seekingalpha.com/news/4612678-qiagen-jumps-after-report-of-takeover-interest-fomr-eqt-advent", "source_name": "Seeking Alpha", "published_at": "2026-07-09T10:31:00", "published_display": "09 Jul 2026 10:31", "sentiment": "positive", "sentiment_pct": 81, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock jumps on reported takeover interest from buyout firms", "summary": "Qiagen NV shares rose 9% after Bloomberg reported that the European molecular testing company is attracting early takeover interest from private equity firms, including EQT AB and Advent, with KKR & Co. also expressing interest. The company, which has seen its shares fall 16% in ", "url": "https://www.investing.com/news/stock-market-news/qiagen-stock-jumps-on-reported-takeover-interest-from-buyout-firms-93CH-4784448", "source_name": "Investing.com", "published_at": "2026-07-09T10:30:00", "published_display": "09 Jul 2026 10:30", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. highlights its diagnostics platform as investors watch global health demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQM2x6X05yM09Wbmk5UXlPU1E3ejlPSVpDNU9kYUw2QlNzc000LXlNM2RieTBXOWdXbFFuRFpaa0EzTDh6ZURudHlxNENhRGdwdVhfcGJnSm9MaElXT21YeXVyOW51SXFvV0pOejFfelZBLTdmanExUVZXRERuVDNQaVZGdWg3RWI4ZURHQ21sMFZQcWR1TXBxdnVMMVk4LTBjYXdWOXBGMFZSMWc3eDB3dHpvU09jNllwTFlhSDhVcFB2cXJUQTFtNGdDRQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T09:16:08+00:00", "published_display": "09 Jul 2026 09:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. builds on diagnostics demand as investors track global healthcare trends", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOektEcWtFUzNWaE1XZ2dUQlNKdnpiN3ZiTkwzUzFIVE9ubU5RQlZPelEtOEphTmJNWW9fNkEyVGVXaDQyRW5MYmVJVDRNODNTQU1id1hLRm5OWi1McS1rNml4VGhCYmR0bmZ4UHN3QTRKbnZ5UGg0WEIzZHc1NXlISG5NTWJYZGVhSGstTDFRamdVWEpJZWhHR2tRNmk1bDlwSWpUUDdmSTN6eUl0NmxtTEtva1lVUGppUFVlZ1ZHZDB1dw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T05:06:29+00:00", "published_display": "09 Jul 2026 05:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. focuses on diagnostics growth and US exposure", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNZ2lQX0k4cl9wZ1hTYmVSNTdZZmhMcllCMG1YUEc0c1dTMzhnZmJqZWNubXZaeWFZVmx0WjdWbGNuUzBLcEtVVmVSSmN0OXF4UjdRUkFNNEE5Q3FBM002ZU9VWmFCTktPNWl4ZFFPNkZTWTlEbVIxUDNMMTMtU256SjRkQ3kxQlN0RFRLVm5KWklUSWVGNE5Hd09qbjFwSUthMnNUbUNRSEdQdjF1QzlqN1JjbVNWUQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-07T06:18:50+00:00", "published_display": "07 Jul 2026 06:18", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. highlights molecular diagnostics growth as investors eye global health demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOQko3MXlYWXFwTHkxSnMxOV9tY1VOWVJqOFpMc2JTYS1LU191dDgzWUM4Rnp1MGNGSVBsSW50OGs4SU1maVVDcHZ1aUg3TVF6Y1hheUNlVjU4cHBqRWl3dk5lRHYtb01xSWRocm9HSFVObUFsd2RjeE5KRHVtWElaMzhvcDBwdW9pX1BzcTBuTXNwYmhzMmVsaWE5eFEwWDFoekxXQVo1Skw4aXJoS1YwQWpSMnZHQkJ4RG90YnVyZFVWa0J5?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-06T06:41:22+00:00", "published_display": "06 Jul 2026 06:41", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors Are Reacting To Qiagen (QGEN) Joining The Russell 1000 Dynamic Index", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T13:31:12+00:00", "published_display": "05 Jul 2026 13:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. updates earnings calendar, shares tracked against diagnostics peers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOUTNqbEpUTW4xd3RUTE5nMEt0ZEJFT25xZVBoYjRYYk56b18xdkwyWFJncVR1cjMwa25pbUhudWk2Ukk5RlBqLU1fRXo5YmZXNlZQMG5ubnExM1o4YXZpSDE3enY4T0MtLTVIS1dnYUlVWTZMNW5HVkFKNVFFbFZRVnQ3Z0ZkNnJmN0NMRHVRZXJtQkw2b1RUazZSZW1yaTVCM0VVYU9RM1o3YWF4MHlZM2ppSWZnekVxUEN4Y01GaWRiUXVTMHE0bXRB?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-26T05:11:57+00:00", "published_display": "26 Jun 2026 05:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen Stock - Friday review and sector comparison", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPMnFsVUVVSFdZT0FrVzRrWDNLN0RiU1U4dG85Nk91amg0X0Mxa1psR1pBb2gzT2dONnl4QU04MkdVVFh6eHYzSGN5MGpndktlSU9uSlZUUDZUY3JDal80RG94OHNtUDEwMWhRa3hBWmNQaV9YXzc4WFVuWVlMTE93Y19iSjd1Um8ycmh6a1BnUXgzZnRBR0w0TWdQTG9wWGNFS1F4ZWQtOC1QMmM?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. Stock (NL0012169213): Analyst Views And Fundamentals In Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPWk5RdUxoR0ZERTVybUUtWmJGMWdpOG1FbEdySG5XRGVCLTVzdHQwMU5XQjBzQW10YjI3bklqNTN2NlRGVGlwaTNtbFVrRVlWU1dIX1hEeVRMS2owZUNrUU1ybDFMU1JjV2oyeHBkdjVmYk55MmZLcjQ2c0s3ME9PWVA3VWQ2ckRBQ0E5WUpQYjdYM3g2dVJ5cmsySXZQTzhmRDdXSzVwUlVaZ2JveGRyQ3ZGdC1veHFIWWMySFFxOE55REx2RDFB?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-16T19:49:10+00:00", "published_display": "16 Jun 2026 19:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. stock (NL0012169213): UBS stake disclosure and AFM voting rights notice keep insider own", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNTDhuR1BYazZuTVY3MEo5bjRvbXdjUnpJak9CeFJsbnktc0NZUTlQemhNYlVYdldYVWhvcFB5V3NWX2FHWlhLT1NKckdiZzlEODZ4MS1kZVRYdkpTUTRYVUtjNXBPQnliNmpLb3E0VjUtMndmVllPbW8yc05RNWxleF8tdVdDcHBuR1ZYMmNTYm9MUHcwMGp2V2xfdTJRM1pNOWJjUDhXVTB2VDZ2NnRoejd6MVI1QXM1ZmktcDlqVXBKZw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-30T07:00:00+00:00", "published_display": "30 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New QIAGEN AI lab assistant is designed to speed experiment planning", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNSkEtd2lYQUdodm5QZW9nYVh6Mkk5SGM1WFQyTXNSR3hZTXhNZHRmODBBMTZZeF9wNGtlUTJKMURrYWY3N3FKN1ZOb3VUR1pMejY5VWMtMUZPanQyMUtxNzRLV0RkQTVTZDZFcTBQWU5zVzRocDExMC1nVkFCRnhZeHhSdDN6Q3JYSGQzeWVtbkJaTDJRRzlMbzg5MlZuaUcwbXhfSFJYVVM3NU1MMUJfOWg3NllIRGRxa3BVXzNB?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird upgrades Qiagen stock rating on valuation after pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQZHl2RUhhMnVpVXdDOFptU1JxUlRMLWFtZm9HMTJzZFJ0ZE1UVElwSTBycTY3emZiUjNCVVRXNXloMnB2ejhNS0w5UGRiUnZlZlQxdmFZS1pEZUNabkxqMEZiS0wtYld3T2FYNm5EMjhERXNJUTI0TU1XWElIUEZZb1NHLVVUMUlSeXNZd2M0c2FPVTd2Skx3LV8zSFhuN2dYV2FLZ3BJbTFhX1NBckZQS1V6OXVKRXVyWjNkNENKWQ?oc=5", "source_name": "Investing.com", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen NV (QGEN) Falls to 7-Year Low as MidEast Tensions Drag Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQSERuR2FRZWZVOVNZMFRTREI3TUlkVkNqYXhVdS1vMzB6SnkxY0stUEdBS2tlWWZIWGhnQndvQUIyUHdJS2hlRmo4X095ejJhUE1GX0k5VUVDMFpSQTBTMUVtQWhnRnJWSFJMdk43NUtkbE5Zd2pZUHY3VEV6YXdVbDJ4Q28wVWswNktPTU9XYng?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen cuts 2026 outlook on lower immigration testing demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOYVBsbV93NDJtY2kzV05WbW5VYldJMFc0YUtHR3ZsTnRGSUplMFdSMldfYnk2VG5VeUc4cmJFdUNKN2c5TTJ1TlR4bmdYN2JGMGhXT3dVTDhBN2Z4NGN5ekVHa3J6WFIwWTZkU0RsdnozREJpb3duWkI1bHgxWU9hR2FhLWs4OVZxUV9OcnhOLUZrS0d3RW1Ta3ZHOXBhMFpQWHNWNVdlZ0lBYjVOaGJtRTA1ZGp4NjdF?oc=5", "source_name": "Investing.com", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeover rumours at Qiagen fuel share price surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNZlZJR3pRV0g3SDd2LVB5dlNURlpFcWNzU3EwX1RkcVc3WS1pQkprNFkwcW1sNEhOSkZCeG94Z3VkWTZiX09lQ2ZRZU4yanJQSFAwaUZvZlRaR3NielloSnBRM1RhaEJPYVFHcjh0aENEU1NQWThFNVozMVZjT2pXSXpRcnFzaEFyVGN5dFVSdE1DUkFKR2phdkdqMHQ0QQ?oc=5", "source_name": "European Biotechnology Magazine", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Have Qiagen Insiders Been Selling Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOSnVkSVBYZlFoZ2MyYjZoM01DMFczaHo2bzBBZjQyT0lQZjNHSHlaNDlMMHdHZTFFWXp6TFl3NzN4UzNDV3BfS1ZtUTBRb1BHVF9PSXB4eGxTM0lacFk2TVl5Sjl6OXV4YS11Z3FvVURzUnJHUWg5Tlc5VV93QU82cExXZ21KRl8tT1JBWE9pSDM0ZFBiME1mV2V4cEotNGl2blp4V2xWLTN1eUNJV3RkZENUWTJhY25p0gG-AUFVX3lxTFBxUW5nU29EVlBFQkVOVTUyNW1BYUZBS2czWURuaDZieVRVYUxrZEdsbHJaZkNRV042dHBYOEsyZ2pKQUI3YnpXM18xV3k2MUNhRmRiUXlfZWlUNTJ4ZEFXN0FGUDNNZ0VBX3ZOOWFUYXBLa3F0NEwzUnRtWnpPNm0tOFBiUGpiSmdyRVUtR0Ztci12OXA2V0YzMktUWk1KaWxIZXBYM0lFT3pvTlhoSVRPbl9BVzZzRU9vRFFYTEE?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-23T07:00:00+00:00", "published_display": "23 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 99, "total_relevant": 57, "sentiment_summary": {"positive": 21, "negative": 8, "neutral": 28, "score": 55, "total": 57, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 16.45, "count": 28}, {"event": "analyst", "label": "Analyst action", "weight": 5.5, "count": 10}, {"event": "earnings", "label": "Earnings", "weight": 4.95, "count": 9}, {"event": "macro", "label": "Macro sensitivity", "weight": 2.75, "count": 5}, {"event": "deals", "label": "Deals and strategy", "weight": 1.65, "count": 3}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}], "positive_events": 21, "negative_events": 8}, "market_context": {"has_market_context": true, "latest_close": 41.51, "latest_week": "2026-07-10", "one_week_move": 4.5, "four_week_move": 13.0, "twelve_week_move": 0.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.568097, "market_dynamics_buy_signal": false, "relative_strength": -16.520509, "fair_value_gap": -4.6, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 49.3891, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+4.5% over one week, +13.0% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Ad-hoc-news.de", "count": 11}, {"label": "MarketBeat", "count": 6}, {"label": "Investing.com", "count": 5}, {"label": "Stock Titan", "count": 4}, {"label": "Moomoo", "count": 4}, {"label": "TradingView", "count": 3}, {"label": "simplywall.st", "count": 3}, {"label": "Market source", "count": 3}], "tiers": [{"label": "Direct company coverage", "count": 57}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 28}, {"label": "Analyst action", "count": 10}, {"label": "Earnings", "count": 9}, {"label": "Macro sensitivity", "count": 5}, {"label": "Deals and strategy", "count": 3}, {"label": "Guidance", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "57", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+4.5% over one week, +13.0% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Qiagen highlights testing tools amid U.S. cyclosporiasis outbreak By Investing.com"}], "updated_at": "2026-07-16T02:16:17.494778+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}